WallStreetZenWallStreetZen

NASDAQ: ALVR
Allovir Inc Stock Ownership - Who owns Allovir?

Insider buying vs selling

Have Allovir Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vikas SinhaOfficer Title President and Chief Financial Officer2024-04-02885$0.77
$683.22Sell
Diana BrainardChief Executive Officer2024-04-021,533$0.77
$1.18kSell
Edward MillerGeneral Counsel2024-04-02368$0.77
$284.10Sell
Brett R. HagenChief Accounting Officer2024-04-02281$0.77
$216.93Sell
Diana BrainardChief Executive Officer2024-02-215,155$0.71
$3.65kSell
Brett R. HagenChief Accounting Officer2024-02-20494$0.70
$343.33Sell
Edward MillerGeneral Counsel2024-02-20385$0.70
$267.58Sell
Diana BrainardChief Executive Officer2024-02-203,097$0.70
$2.15kSell
Vikas SinhaOfficer Title President and Chief Financial Officer2024-02-202,893$0.70
$2.01kSell
Brett R. HagenChief Accounting Officer2024-02-0811,150$0.67
$7.49kSell

1 of 5

ALVR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALVR insiders and whales buy or sell their stock.

ALVR Shareholders

What type of owners hold Allovir Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David Hallal46.13%52,992,078$39.32MInsider
Morana Jovanembiricos46.11%52,964,650$39.30MInsider
Vikas Sinha41.71%47,911,976$35.55MInsider
Ansbert Gadicke26.23%30,125,933$22.35MInsider
Elevatebio LLC14.52%16,674,766$12.37MInsider
Gilead Sciences Inc14.48%16,635,286$12.34MInsider
F2 Mg Ltd8.56%9,828,091$7.29MInsider
John Robert Wilson7.60%8,727,908$6.48MInsider
Artal Group Sa5.74%6,597,167$4.90MInstitution
Fmr LLC4.96%5,692,782$4.22MInstitution

1 of 3

ALVR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALVR14.62%85.38%Net BuyingNet Selling
ELTX3.25%92.54%Net Buying
SLS6.21%13.47%Net Selling
MIST33.44%24.16%
CNTB12.92%0.00%

Allovir Stock Ownership FAQ

Who owns Allovir?

Allovir (NASDAQ: ALVR) is owned by 36.46% institutional shareholders, 212.94% Allovir insiders, and 0.00% retail investors. David Hallal is the largest individual Allovir shareholder, owning 52.99M shares representing 46.13% of the company. David Hallal's Allovir shares are currently valued at $39.74M.

If you're new to stock investing, here's how to buy Allovir stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.